472 Indiana CTSI Think Tank Program

dc.contributor.authorGarcia, Kara
dc.contributor.authorPortonovo, Padma
dc.contributor.authorGarci, Kara
dc.contributor.departmentMedicine, School of Medicine
dc.date.accessioned2025-01-29T11:28:28Z
dc.date.available2025-01-29T11:28:28Z
dc.date.issued2022
dc.description.abstractOBJECTIVES/GOALS: The Think Tanks’ aim to assist faculty innovators along the path from discovery to commercialization; serving as a one-stop-shop where investigators can access advice, pilot funds, and direction toward other available resources within the Indiana CTSI. METHODS/STUDY POPULATION: Faculty receive guidance from a pool of advisors in the drug and device industry, as well as their respective university commercialization offices; who serve as an essential resource for a wide range of scientific, technical, clinical, business, and regulatory questions. Investigators submit a simple intake form to connect with a project facilitator for detailed guidance prior to formal meetings. Projects are guided from start to finish with robust tracking and milestone-based funding to help generate data for Investigational New Drug (IND) or Investigational Device Exemption (IDE) applications. Project tracking is conducted using REDCap, which is used for all investigator submissions, with internal processes also tracked in REDCap. RESULTS/ANTICIPATED RESULTS: From Feb-Aug 2021; the Think Tanks provided feedback to 15 drug projects and 6 medical device projects. This included 12 from Indiana University; 4 from Purdue University; and 5 from the University of Notre Dame. Interestingly; drug innovations were submitted primarily by tenure track faculty (100%) with a history of NIH/NSF funding (50%); while device innovations were submitted primarily by clinical faculty without a history of NIH/NSF funding (66%). Based on first-round feedback, a total of approximately $3;400 in pilot funds were provided. Efforts are underway to obtain survey-based feedback from all applicants to date; which will be used to inform future program modifications. DISCUSSION/SIGNIFICANCE: The budding “Think Tank” program provides faculty with a broad perspective of the entire drug and medical device development process, helping investigators understand the critical interplay development stages. Future work seeks to enhance faculty engagement in, and understanding of the commercialization process across Indiana CTSI institutions.
dc.eprint.versionFinal published version
dc.identifier.citationGarcia K, Portonovo P, Garci K. 472 Indiana CTSI Think Tank Program. Journal of Clinical and Translational Science. 2022;6(s1):94-94. doi:10.1017/cts.2022.276
dc.identifier.urihttps://hdl.handle.net/1805/45571
dc.language.isoen_US
dc.publisherCambridge University Press
dc.relation.isversionof10.1017/cts.2022.276
dc.relation.journalJournal of Clinical and Translational Science
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internationalen
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0
dc.sourcePublisher
dc.subjectIndiana CTSI
dc.subjectThink Tanks
dc.subjectFaculty innovators
dc.subjectDiscovery
dc.subjectCommercialization
dc.title472 Indiana CTSI Think Tank Program
dc.typeAbstract
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Garcia2022Indiana-CCBYNCND.pdf
Size:
51.03 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.04 KB
Format:
Item-specific license agreed upon to submission
Description: